Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral Clearance
Journal of Transplantation · 2009
DOI: 10.1155/2009/297528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Transplantation, 2009. Verfasst von M Ghabril und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Clarian/Indiana University School of Medicine, 975 W Walnut Street 1B327, Indianapolis, IN 46202-5181,…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Background
Hepatitis C virus (HCV) nondetectability in the liver may predict a sustained viral response (SVR) in patients with an end of treatment response. HCV RNA can be detected in liver tissue by in situ hybridization (ISH).
Aim
To determine if HCV nondetectability in liver allografts by ISH can predict SVR in patients who cleared virus serologically on treatment.
Methods
Twenty five patients with undetectable serum HCV on Interferon/Ribavirin therapy for HCV recurrence post liver transplant (LT) were studied. All had biopsies at 4 months post LT (baseline) and follow up with HCV ISH analysis performed.
Results
10 were ISH positive (group 1); 15 were ISH negative (group 2). Groups 1 and 2 had similar patient, donor, and viral characteristics at LT, as well as treatment duration at the time of the ISH assayed liver biopsy ( 13 ± 16 versus 10 ± 4 months P = .24). However, group 1 had longer total treatment duration ( 24 ± 10 versus 14 ± 5 months, P = .001). Eight (80%) group 1 and 9 (60%) group 2 patients achieved SVR. Mean grade and stage (modified Ishak score) were similar at 4 months, however, group 1 had higher grade ( 3 ± 1.7 versus 1.6 ± 1.3 , P = .039) and stage ( 1.4 ± 1.4 versus 0.5 ± 0.6 , P = .084) on the ISH assayed biopsy, after similar post LT intervals ( 23 ± 10 versus 24 ± 12 months, P = .91).
Conclusion
Allograft HCV ISH nondetectability does not predict SVR in treatment responsive HCV recurrence, but is associated with less severe histologic disease.
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Clarian/Indiana University School of Medicine, 975 W Walnut Street 1B327, Indianapolis, IN 46202-5181, USA.
Zitieren
APA
Ghabril, M., Dickson, R. C., Krishna, M., Lloyd, R., Aranda-Michel, J., Keaveny, A., Satyanarayana, R., & Bonatti, H. (2009). Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral Clearance. Journal of Transplantation. https://doi.org/10.1155/2009/297528
Vancouver
Ghabril M, Dickson RC, Krishna M, Lloyd R, Aranda-Michel J, Keaveny A, et al. Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral Clearance. Journal of Transplantation. 2009. doi:10.1155/2009/297528
BibTeX
@article{Ghabril2009,
author = {Ghabril, M and Dickson, R C and Krishna, M and Lloyd, R and Aranda-Michel, J and Keaveny, A and Satyanarayana, R and Bonatti, H},
title = {Persistence of Hepatitis C RNA in Liver Allografts Is Associated with Histologic Progression Independent of Serologic Viral Clearance},
journal = {Journal of Transplantation},
year = {2009},
doi = {10.1155/2009/297528}
}
EUVIMED